Dysregulation of bile acid homeostasis in cirrhosis and non-alcoholic steatohepatitis leads to increased hepatic bile acid inflammation and reduced FXR signaling, which is a risk factor for the development of HCC2,25,26. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.